Recombinant Human ANXA9 Protein，His

ANXA9, or Annexin A9, is a member of the annexin family of calcium-dependent phospholipid-binding proteins, which are known to play crucial roles in various cellular processes, including membrane trafficking, apoptosis, and inflammation. Recent studies have highlighted ANXA9's potential involvement in cancer biology, particularly its role in tumor growth and metastasis. It has been observed that ANXA9 expression levels can be altered in several types of cancer, suggesting its potential as a biomarker for cancer diagnosis and prognosis. In addition, ANXA9 appears to interact with various signaling pathways, influencing processes such as cell migration and invasion. Given its pivotal role, researchers have focused on producing recombinant ANXA9 protein to study its structure-function relationship and elucidate its biological functions in detail. Recombinant protein production allows for the generation of large quantities of pure protein, facilitating biochemical assays and structural analyses, which can provide insights into the mechanisms by which ANXA9 contributes to disease pathology. Furthermore, understanding the functional properties of ANXA9 can pave the way for novel therapeutic approaches targeting this protein in cancer treatment and other diseases. The ongoing research endeavors involving recombinant ANXA9 aim to clarify its role in cellular physiology and pathology, potentially leading to new diagnostic and therapeutic strategies in oncology and beyond.